Home | Help | Feedback | Subscriptions | Archive | Search | Table of Contents

This Article Full Text Full Text (PDF, 489K) PPT slides of all figures Alert me when this article is cited Citation Map Services Email this article Similar articles in this journal Similar articles in PubMed Alert me to new content in the JEM Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via CrossRef Citing Articles via Google Scholar Google Scholar Articles by Jacobi, A. M. Articles by Diamond, B. Search for Related Content PubMed PubMed Citation Articles by Jacobi, A. M. Articles by Diamond, B. Social Bookmarking                            What's this?

Annett M. Jacobi^a,b and Betty Diamond^a,b

^a A.M.J. is at Department of Rheumatology and Clinical Immunology, Charite University Hospital, 10117 Berlin, Germany.
^b B.D. is at Departments of Medicine and Microbiology, Columbia University Medical Center New York, NY 10032.

CORRESPONDENCE B.D.: bd2137{at}columbia.edu

Abstract
The autoimmune disease systemic lupus erythematosus (SLE) is caused by a failure of B cell tolerance. Recent studies in mouse models of SLE have identified several distinct tolerance checkpoints that must each function appropriately to protect against disease. However, studies of B cell repertoire selection in humans are essential to understand which checkpoints are defective in human autoimmune diseases.

CiteULike

Complore

Connotea

Del.icio.us

Digg

Facebook

Reddit

Technorati

Twitter

This article has been cited by other articles:

• LEE, H.-T., SHIAO, Y.-M., WU, T.-H., CHEN, W.-S., HSU, Y.-H., TSAI, S.-F., TSAI, C.-Y. (2010). Serum BLC/CXCL13 Concentrations and Renal Expression of CXCL13/CXCR5 in Patients with Systemic Lupus Erythematosus and Lupus Nephritis. The Journal of Rheumatology 37: 45-52 [Abstract] [Full Text]  
• Petri, M, Singh, S, Tesfasyone, H, Dedrick, R, Fry, K, Lal, P., Williams, G, Bauer, J., Gregersen, P., Behrens, T., Baechler, E. (2009). Longitudinal expression of type I interferon responsive genes in systemic lupus erythematosus. Lupus 18: 980-989 [Abstract]  
• Driver, C B, Ishimori, M, Weisman, M H (2008). The B cell in systemic lupus erythaematosus: a rational target for more effective therapy. Ann Rheum Dis 67: 1374-1381 [Abstract] [Full Text]  
• Forster, N., Gallinat, S., Jablonska, J., Weiss, S., Elsasser, H.-P., Lutz, W. (2007). p300 Protein Acetyltransferase Activity Suppresses Systemic Lupus Erythematosus-Like Autoimmune Disease in Mice. J. Immunol. 178: 6941-6948 [Abstract] [Full Text]  
• Mazari, L., Ouarzane, M., Zouali, M. (2007). Subversion of B lymphocyte tolerance by hydralazine, a potential mechanism for drug-induced lupus. Proc. Natl. Acad. Sci. USA 104: 6317-6322 [Abstract] [Full Text]  
• Paul, E., Nelde, A., Verschoor, A., Carroll, M. C. (2007). Follicular exclusion of autoreactive B cells requires Fc{gamma}RIIb. Int Immunol 19: 365-373 [Abstract] [Full Text]  
• Gilbert, J. A., Kalled, S. L., Moorhead, J., Hess, D. M., Rennert, P., Li, Z., Khan, M. Z., Banga, J. P. (2006). Treatment of Autoimmune Hyperthyroidism in a Murine Model of Graves' Disease with Tumor Necrosis Factor-Family Ligand Inhibitors Suggests a Key Role for B Cell Activating Factor in Disease Pathology. Endocrinology 147: 4561-4568 [Abstract] [Full Text]  
• Lartigue, A., Courville, P., Auquit, I., Francois, A., Arnoult, C., Tron, F., Gilbert, D., Musette, P. (2006). Role of TLR9 in Anti-Nucleosome and Anti-DNA Antibody Production in lpr Mutation-Induced Murine Lupus. J. Immunol. 177: 1349-1354 [Abstract] [Full Text]  

Home | Help | Feedback | Subscriptions | Archive | Search

TABLE OF CONTENTS